Cited by 1,298Liver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic DiseasesAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

Open access

Xu, Aimin, Wang, Yu, Keshaw, Hussila, Xu, Lance Yi, Lam, Karen S.L., Cooper, Garth J.S.·2003·Journal of Clinical Investigation

DOI 10.1172/jci200317797PMC PMC162288

Open this paper in CoChat — free account Open PDF

Abstract

Adiponectin has recently been shown to be a promising candidate for the treatment of obesity-associated metabolic syndromes. Replenishment of recombinant adiponectin in mice can decrease hyperglycemia, reverse insulin resistance, and cause sustained weight loss without affecting food intake. Here we report its potential roles in alcoholic and nonalcoholic fatty liver diseases in mice. Circulating concentrations of adiponectin decreased significantly following chronic consumption of high-fat ethanol-containing food. Delivery of recombinant adiponectin into these mice dramatically alleviated hepatomegaly and steatosis (fatty liver) and also significantly attenuated inflammation and the elevated levels of serum alanine aminotransferase. These therapeutic effects resulted partly from the ability of adiponectin to increase carnitine palmitoyltransferase I activity and enhance hepatic fatty acid oxidation, while it decreased the activities of two key enzymes involved in fatty acid synthesis, including acetyl-CoA carboxylase and fatty acid synthase. Furthermore, adiponectin treatment could suppress the hepatic production of TNF-α and plasma concentrations of this proinflammatory cytokine. Adiponectin was also effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice. These results demonstrate a novel mechanism of adiponectin action and suggest a potential clinical application of adiponectin and its agonists in the treatment of liver diseases.

Integrity signals

Registry

Crossref · 10.1172/jci200317797

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Novel Modulator for Endothelial Adhesion Molecules
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,158
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007

Flagged first, then by citations

Show all 68 references

Research works printed but not linked: 6

10.1073/pnas.041591798 · DOI
Kubota, 2002, J. Biol. Chem., 277, 35863
Wilkes, 1996, Am. J. Physiol., 271, E477
Winder, 1999, Am. J. Physiol., 277, E1
10.1210/jc.84.5.1513 · DOI
Funabiki, 2002, Diabetes., 51(Suppl. 2), 32a

Sorted by citations

Items 601–700 of 998

Quercetin ameliorates insulin sensitivity and liver steatosis partly by increasing adiponectin expression in ob/ob mice
Choi, H., Jeong, S.-M., Huh, G. H., & Kim, J.-I. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0036-9 · Cited by 42
Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice
Correnti, J., Juskeviciute, E., Swarup, A., & Hoek, J. B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00395.2013 · Cited by 42
Organ–Organ Crosstalk and Alcoholic Liver Disease
Poole, L. G., Dolin, C. E., & Arteel, G. E. (2017) · Biomolecules · doi:10.3390/biom7030062 · Cited by 42
Research progress into the physiological changes in metabolic pathways in waterfowl with hepatic steatosis
Wei, R., Han, C., Deng, D., Ye, F., Gan, X., Liu, H., Li, L., Xu, H., & Wei, S. (2020) · British Poultry Science · doi:10.1080/00071668.2020.1812527 · Cited by 48
Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease
Kaser, S., Ebenbichler, C. F., & Tilg, H. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02327.x · Cited by 42
Hepatitis C virus infection and nonalcoholic steatohepatitis.
Patel, A. A., & Harrison, S. A. (2012) · Europe PMC (PubMed Central) · Cited by 42
Pathogenesis of Alcoholic Fatty Liver a Narrative Review
Seitz, H. K., Moreira, B., & Neuman, M. G. (2023) · Life · doi:10.3390/life13081662 · Cited by 41
Globular adiponectin inhibits ethanol-induced apoptosis in HepG2 cells through heme oxygenase-1 induction
Nepal, S., Kim, M. J., Subedi, A., Lee, E.-S., Yong, C. S., Kim, J., Kang, W., Kwak, M.-K., Arya, D. S., & Park, P. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.019 · Cited by 41
Adiponectin protects L eydig cells against proinflammatory cytokines by suppressing the nuclear factor‐κ B signaling pathway
Wu, L., Xu, B., Fan, W., Zhu, X., Wang, G., & Zhang, A. (2013) · FEBS Journal · doi:10.1111/febs.12391 · Cited by 42
Identification of Putative Receptors for the Novel Adipokine CTRP3 Using Ligand-Receptor Capture Technology
Li, Y., Ozment, T. R., Wright, G. L., & Peterson, J. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164593 · Cited by 41
Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis
Silva, T. E., Silva, M. C., Corrêa, C. G., Denardin, G., Alencar, M. L. A., Coelho, M. S. P. H., Wildner, L. M., Bazzo, M. L., González‐Chica, D. A., Dantas-Corrêa, E. B., et al. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8660 · Cited by 41
Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease
Meng, F.-G., Zhang, X., Liu, S.-X., Wang, Y., & Zeng, T. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109176 · Cited by 41
Self-citation
New concepts in the pathogenesis of alcoholic liver disease
Albano, E. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.6.749 · Cited by 41
The Role of Adiponectin during Pregnancy and Gestational Diabetes
Gruber, B. L. M., & Dolinsky, V. W. (2023) · Life · doi:10.3390/life13020301 · Cited by 48
Excessive alcohol consumption: a driver of metabolic dysfunction and inflammation
Lee, J., Lee, J., & Kang, H. (2025) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1670769 · Cited by 44
Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
Ochi, A., Mori, K., Emoto, M., Nakatani, S., Morioka, T., Motoyama, K., Fukumoto, S., Imanishi, Y., Koyama, H., Ishimura, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088704 · Cited by 40
Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels
Jiang, L., Li, L., Hong, X.-F., Li, Y., & Zhang, B. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328317f4b5 · Cited by 40
Role of AMP-activated Protein Kinase and Adiponectin during Development of Hepatic Steatosis in High-fat Diet-induced Obesity in Rats
Ha, S. K., Kim, J., & Chae, C. (2011) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2010.11.011 · Cited by 41
WISP1 promotes non‐alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling
Jung, T. W., Kang, C. M., Goh, J., Chae, S. I., Kim, H., Lee, T. J., El‐Aty, A. M. A., & Jeong, J. H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26449 · Cited by 40
Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice
Shu, R., Zhang, F., Wang, F., Feng, D., Li, X., Ren, W., Wu, X.-L., Yang, X. F., Liao, X., Huang, L. H., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.63 · Cited by 44
Regulation of Kupffer cell activity during chronic ethanol exposure: Role of adiponectin
Park, P., Thakur, V., Pritchard, M. T., McMullen, M. R., & Nagy, L. E. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04580.x · Cited by 40
Linking adiponectin to proteinuria
Ahima, R. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35655 · Cited by 40
Prevention of steatohepatitis by pioglitazone: Implication of adiponectin-dependent inhibition of SREBP-1c and inflammation
Morais, A. D. S., Lebrun, V., Abarca‐Quinones, J., Brichard, S. M., Hue, L., Guigas, B., Viollet, B., & Leclercq, I. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.027 · Cited by 41
Evidence that α-Calcitonin Gene-Related Peptide Is a Neurohormone that Controls Systemic Lipid Availability and Utilization
Danaher, R., Loomes, K. M., Leonard, B. L., Whiting, L., Hay, D. L., Xu, L. Y., Kraegen, E. W., Phillips, A. R. J., & Cooper, G. J. S. (2007) · Endocrinology · doi:10.1210/en.2007-0583 · Cited by 40
Self-citation
Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver
Chen, Y., Zhang, C., Zhao, X., Xie, K., & Zeng, T. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.08.009 · Cited by 39
CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
Najjar, S. M., & Russo, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0407-3 · Cited by 40
Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease
Zhang, H., Niu, Y., Gu, H., Lü, S., Zhang, W., Li, X., YANG, Z. K., Qin, L., & Su, Q. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22709 · Cited by 39
Upregulation of UCP2 by Adiponectin: The Involvement of Mitochondrial Superoxide and hnRNP K
Zhou, M., Xu, A., Tam, P. K. H., Lam, K. S. L., Huang, B., Liang, Y. Q., Lee, I., Wu, D., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032349 · Cited by 38
Self-citation
1. Fatty Liver and Non-Alcoholic Steatohepatitis
Saito, T., Misawa, K., & Kawata, S. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.1784 · Cited by 39
Changes in liver tests during 1‐year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide
Belcher, G., & Schernthaner, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01595.x · Cited by 39
Cytokines in Liver Diseases
Muriel, P. (2007) · Wiley eBooks · doi:10.1002/9780470516751.ch14 · Cited by 39
Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
Yilmaz, Y. N., Kedrah, A. E., & Ozdogan, O. C. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4387 · Cited by 41
Stratification of Risk of Death in Severe Acute Alcoholic Hepatitis Using a Panel of Adipokines and Cytokines
Rachakonda, V. P., Gabbert, C. C., Raina, A., Li, H., Malik, S. M., DeLany, J. P., & Behari, J. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12558 · Cited by 38
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome
Lucero, D., Zago, V., Lopez, G. I., Graffigna, M. N., Fainboim, H. A., Miksztowicz, V., Meroño, T., Belli, S., Levalle, O. A., Wikinski, R. L. W., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.025 · Cited by 38
Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives
Federico, A., Trappoliere, M., & Loguercio, C. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.04.009 · Cited by 38
Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats
Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A., & El‐Demerdash, E. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115101 · Cited by 39
The liver steatosis severity and lipid characteristics in primary biliary cholangitis
Zhang, Y., Hu, X., Chang, J. K., Chen, J., Han, X., Zhang, T., Shen, J., Shang, N., Han, J., Wang, H., et al. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01974-4 · Cited by 40
Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice
Gruber, B. L. M., Cole, L., Xiang, B., Fonseca, M. A., Klein, J., Hatch, G. M., Doucette, C. A., & Dolinsky, V. W. (2022) · Diabetologia · doi:10.1007/s00125-021-05649-3 · Cited by 43
High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
Liu, C., Chen, P., Lai, M., Liu, C., Chen, C.-L., Kao, J., & Chen, D. (2008) · Hepatology International · doi:10.1007/s12072-008-9111-0 · Cited by 38
Alcohol linked to enhanced angiogenesis in rat model of choroidal neovascularization
Bora, P. S., Kaliappan, S., Xu, Q., Kumar, S., Wang, Y., Kaplan, H. J., & Bora, N. S. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05163.x · Cited by 39
Self-citation
A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance
Zheng, H., Li, S., Ma, L., Cheng, L., Deng, C., Chen, Z., Xie, C., Xiang, M., Jiang, W., & Chen, L. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.033 · Cited by 38
Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
Yoon, D., Lee, S., Park, H. S., Lee, J. H., Park, J. S., Cho, K.-H., & Kim, S. M. (2005) · Journal of Korean Medical Science · doi:10.3346/jkms.2005.20.3.421 · Cited by 38
Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease
Uribe, M., Zamora‐Valdés, D., Moreno-Portillo, M., Bermejo-Martínez, L., Pichardo-Bahena, R., González, H. A. B., Ponciano‐Rodríguez, G., Uribe, M. H., Medina‐Santillán, R., & Méndez‐Sánchez, N. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31890-3 · Cited by 37
Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease
Kim, S. G., Kim, H. Y., Seo, J. A., Lee, K. W., Oh, J. H., Kim, N. H., Choi, K. M., Baik, S. H., & Choi, D. S. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01842 · Cited by 38
Adipokines and liver fibrosis.
Marra, F., Aleffi, S., Bertolani, C., Petrai, I., & Vizzutti, F. (2005) · PubMed · Cited by 38
Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation
Guri, A. J., & Bassaganya-Riera, J. (2010) · Obesity · doi:10.1038/oby.2010.230 · Cited by 37
Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression
Ilan, Y. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13833 · Cited by 36
The role of AdipoR1 and AdipoR2 in liver fibrosis
Alzahrani, B., Iseli, T. J., Ramezani–Moghadam, M., Ho, V., Wankell, M., Sun, E. J., Qiao, L., George, J., & Hebbard, L. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.012 · Cited by 38
Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice
Kanuri, G., Landmann, M., Priebs, J., Spruss, A., Löscher, M., Ziegenhardt, D., Röhl, C., Degen, C., & Bergheim, I. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0929-7 · Cited by 36
Alcohol intake modulates hormonal activity of adipose tissue.
Pravdova, E., & Fickova, M. (2006) · PubMed · Cited by 36
Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway
Song, C., Shi, J. G., Zeng, X. Y., Zhang, Y., Xie, W., & Chen, Y.-X. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.01.020 · Cited by 36
A novel aminosterol reverses diabetes and fatty liver disease in obese mice
Takahashi, N., Qi, Y., Patel, H. R., & Ahima, R. S. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.05.006 · Cited by 36
Adipokines--targeting a root cause of cardiometabolic risk
Bakhai, A. (2008) · QJM · doi:10.1093/qjmed/hcn066 · Cited by 37
Obesity-Associated Hepatosteatosis and Impairment of Glucose Homeostasis Are Attenuated by Haptoglobin Deficiency
Lisi, S., Gamucci, O., Vottari, T., Scabia, G., Funicello, M., Marchi, M., Galli, G., Arisi, I., Brandi, R., D’Onofrio, M., et al. (2011) · Diabetes · doi:10.2337/db10-1536 · Cited by 37
Adiponectin in Asthma and Obesity: Protective Agent or Risk Factor for More Severe Disease?
Azambuja, R. D. L., Azambuja, L. S. E. D. C. S., da Costa, C. H., & Rufino, R. (2015) · Lung · doi:10.1007/s00408-015-9793-8 · Cited by 36
Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
Grigorescu, M. D., Radu, C., Crișan, D., Grigorescu, M., Serban, A., Neculoiu, D., Rusu, M., & Acalovschi, M. (2008) · PubMed · Cited by 35
Metformin-Mediated Bambi Expression in Hepatic Stellate Cells Induces Prosurvival Wnt/β-Catenin Signaling
Subramaniam, N., Sherman, M. H., Rao, R., Wilson, C. L., Coulter, S., Atkins, A. R., Evans, R. M., Liddle, C., & Downes, M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0053 · Cited by 35
Hyperoside Protected Against Oxidative Stress-Induced Liver Injury via the PHLPP2-AKT-GSK-3β Signaling Pathway In Vivo and In Vitro
Xing, H., Fu, R., Cheng, C., Cai, Y., Wang, X., Deng, D., Gong, X., & Chen, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01065 · Cited by 35
Fibrosis in the Liver
Lee, Y., & Friedman, S. L. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00006-4 · Cited by 37
Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms
Engl, J., Sturm, W., Sandhofer, A., Kaser, S., Tschoner, A., Tatarczyk, T., Weiss, H., Tilg, H., Patsch, J. R., & Ebenbichler, C. F. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01929.x · Cited by 35
Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome.
Broedl, U. C., Lehrke, M., Fleischer-Brielmaier, E., Tietz, A. B., Nagel, J. M., Göke, B., Lohse, P., & Parhofer, K. G. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-11 · Cited by 35
Adipocytokines and Hepatocellular Carcinoma
Wieser, V. E., Moschen, A. R., & Tilg, H. (2012) · Digestive Diseases · doi:10.1159/000341702 · Cited by 34
Fatty Liver Disease
TINIAKOS, D. G., Anstee, Q. M., & Burt, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00005-4 · Cited by 35
Effects of calycosin against high‐fat diet‐induced nonalcoholic fatty liver disease in mice
Duan, X., Meng, Q., Wang, C., Liu, Z., Sun, H., Huo, X., Sun, P., Ma, X., Peng, J., & Liu, K. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13884 · Cited by 34
Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3‐L1 adipocytes
Xu, A., Wong, L. C., Wang, Y., Xu, J. Y., Cooper, G. J. S., & Lam, K. S. L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.020 · Cited by 34
Self-citation
Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes
Wanninger, J., Neumeier, M., Bauer, S., Weiß, T. S., Eisinger, K., Walter, R. B., Dorn, C., Hellerbrand, C., Schäffler, A., & Buechler, C. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.003 · Cited by 34
Hypoadiponectinemia Is Closely Associated With Nonalcoholic Hepatic Steatosis in Obese Subjects
Targher, G., Bertolini, L., & Zenari, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2085 · Cited by 34
Ganoderma lucidum repress injury of ethanol-induced steatohepatitis via anti-inflammation, anti-oxidation and reducing hepatic lipid in C57BL/6J mice
Chung, D.-J., Yang, M., Li, Y.-R., Chen, W. J., Hung, C.-Y., & Wang, C. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.03.059 · Cited by 34
Adiponectin-Secretion-Promoting Phenylethylchromones from the Agarwood of Aquilaria malaccensis
Ahn, S., Ma, C. T., Choi, J., An, S., Lee, M. Y., Le, T. H. V., Pyo, J. J., Lee, J., Choi, M. S., Kwon, S. W., et al. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b00635 · Cited by 34
Plasma Adiponectin Decrease in Women with Nonalcoholic Fatty Liver
Matsubara, M. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.587 · Cited by 34
Adiponectin Mediates the Suppressive Effect of Rosiglitazone on Plasminogen Activator Inhibitor-1 Production
Hoo, R. L. C., Chow, W. S., Yau, M.-H., Xu, A., Tso, A. W. K., Tse, H., Fong, C. H.-Y., Tam, S., Chan, L., & Lam, K. S. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.152462 · Cited by 34
Self-citation
Adiponectin Replacement Therapy Attenuates Myocardial Damage in Leptin-deficient Mice with Viral Myocarditis
Takahashi, T., Saegusa, S., Sumino, H., Nakahashi, T., Iwai, K., Morimoto, S., & Kanda, T. (2005) · Journal of International Medical Research · doi:10.1177/147323000503300208 · Cited by 33
Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes
Salem, G. A., Mohamed, A. A.-R., Khater, S. I., Noreldin, A. E., Alosaimi, M. E., Alansari, W. S., Shamlan, G. H., Eskandrani, A. A., Awad, M. M., El‐Shaer, R. A. A., et al. (2023) · Gene · doi:10.1016/j.gene.2023.147670 · Cited by 37
Hepatic Effects of Rosiglitazone in Rats with the Metabolic Syndrome
Ackerman, Z., Oron‐Herman, M., Pappo, O., Peleg, E., Safadi, R., Schmilovitz‐Weiss, H., & Grozovski, M. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00553.x · Cited by 33
Serum adiponectin in chronic hepatitis C and B
Siagris, D., Vafiadis, G., Michalaki, M. A., Lekkou, A., Starakis, I., Makri, M. G., Margaritis, V., Christofidou, M., Tsamandas, A. C., & Labropoulou‐Karatza, C. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00850.x · Cited by 33
Effects of Lotus Root (the Edible Rhizome ofNelumbo nucifera) on the Deveolopment of Non-Alcoholic Fatty Liver Disease in Obese Diabeticdb/dbMice
Tsuruta, Y., Nagao, K., Shirouchi, B., Nomura, S., Tsuge, K., Koganemaru, K., & Yanagita, T. (2012) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110745 · Cited by 33
Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes
Rattarasarn, C. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2005.01521.x · Cited by 34
Retracted: Fat-Derived Hormone Adiponectin Combined with FTY720 Significantly Improves Small-for-Size Fatty Liver Graft Survival
Man, K., Zhao, Y., Xu, A., Lo, C. M., Lam, K. S. L., Ng, T., Ho, J. W., Sun, C. K.-W., Lee, T. K., LI, X., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01201.x · Cited by 32
Self-citation
Retracted
The Therapeutic Potential of the Adiponectin Pathway
Gu, W., & Li, Y. (2011) · BioDrugs · doi:10.2165/11594790-000000000-00000 · Cited by 32
Environmental and Genetic Determinants of Fatty Liver in Humans
Kantartzis, K., Schick, F., Häring, H., & Stefan, N. (2010) · Digestive Diseases · doi:10.1159/000282082 · Cited by 32
The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury
Zelber‐Sagi, S., Ratziu, V., Zvibel, I., Goldiner, I., Blendis, L. M., Morali, G. A., Halpern, Z., & Oren, R. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834f15dd · Cited by 32
Diabetes Mellitus, Inflammation, Obesity: Proposed Treatment Pathways for Current and Future Therapies
Sonnett, T. E., Levien, T. L., Gates, B. J., Robinson, J. D., & Campbell, R. K. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m640 · Cited by 32
Adiponectin decreases lipids deposition by p38 MAPK/ATF2 signaling pathway in muscle of broilers
Yan, J., Gan, L., Qi, R., & Sun, C. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2821-y · Cited by 32
MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis
Wanninger, J., Walter, R. B., Bauer, S., Eisinger, K., Schäffler, A., Dorn, C., Weiß, T. S., Hellerbrand, C., & Buechler, C. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.07.001 · Cited by 32
Non-alcoholic Steatohepatitis: An Overview
Shifflet, A., & Wu, G. Y. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60026-7 · Cited by 32
Adiponectin Deficiency Promotes the Production of Inflammatory Mediators While Severely Exacerbating Hepatic Injury in Mice with Polymicrobial Sepsis
Uji, Y., Yamamoto, H., Maeda, K., Tsuchihashi, H., Akabori, H., Shimizu, T., Endo, Y., Shimomura, I., & Tani, T. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.12.021 · Cited by 32
Nonalcoholic fatty liver disease and obesity.
Salgado, W., dos Santos, J. S., Sankarankutty, A., & Silva, O. D. C. E. (2006) · Acta Cirurgica Brasileira · doi:10.1590/s0102-86502006000700017 · Cited by 16
FGF21 controls hepatic lipid metabolism via sex-dependent interorgan crosstalk
CHAFFIN, A. T. B., Larson, K. R., Huang, K.-P., Wu, C.-T., Nadejda, G., Fang, Y., Jayakrishnan, D., Sauza, K. A. S., Sims, L. C., Mohajerani, N., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155848 · Cited by 31
Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α
Liu, T., Luo, X., Li, Z., Wu, J.-C., Luo, S., & Xu, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i36.5451 · Cited by 31
Regulation of adiponectin on lipid metabolism in large yellow croaker (Larimichthys crocea)
Ji, R., Xu, X., Xiang, X., Zhu, S., Li, Y., Mai, K., & Ai, Q. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158711 · Cited by 31
Drug‐like sphingolipid SH‐BC‐893 opposes ceramide‐induced mitochondrial fission and corrects diet‐induced obesity
Jayashankar, V., Selwan, E. M., Hancock, S. E., Verlande, A., Goodson, M. O., Eckenstein, K. H., Milinkeviciute, G., Hoover, B., Chen, B., Fleischman, A. G., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013086 · Cited by 31
Lupinus angustifolius Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE−/− Mice
Santos‐Sánchez, G., Cruz‐Chamorro, I., Álvarez‐Ríos, A. I., Fernández-Santos, J. M., Vázquez‐Román, V., Rodríguez-Ortiz, B., Álvarez‐Sánchez, N., Álvarez‐López, A. I., Millán-Linares, M. C., Millán, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10081222 · Cited by 32
Non‐Alcoholic Fatty Liver and Non‐Alcoholic Steatohepatitis
Farrell, G. C. (2007) · doi:10.1002/9780470691861.ch13 · Cited by 31
Adiponectin downregulates TNF-α expression in degenerated intervertebral discs
Yuan, B., Huang, L., Yan, M., Zhang, S., Zhang, Y., Jin, B., Ma, Y., & Luo, Z. (2018) · Spine · doi:10.1097/brs.0000000000002364 · Cited by 30
Modulation of Liver Fibrosis by Adipokines
Marra, F., Navari, N., Vivoli, E., Galastri, S., & Provenzano, A. (2011) · Digestive Diseases · doi:10.1159/000329799 · Cited by 30
Adiponectin and markers of metabolic syndrome in obese children and adolescents: impact of 8-mo regular physical exercise program
Nascimento, H., Costa, E. M., Rocha, S., Lucena, C., Rocha‐Pereira, P., Rêgo, C., Mansilha, H. F., Quintanilha, A. T., Aires, L., Mota, J. A. P. S., et al. (2014) · Pediatric Research · doi:10.1038/pr.2014.73 · Cited by 30
Adipose Inflammation and Macrophage Infiltration After Binge Ethanol and Burn Injury
Qin, Y., Hamilton, J. L., Bird, M. D., Chen, M. M., Ramírez, L., Zahs, A., Kovacs, E. J., & Makowski, L. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12210 · Cited by 30
A Newly Identified CG301269 Improves Lipid and Glucose Metabolism Without Body Weight Gain Through Activation of Peroxisome Proliferator–Activated Receptor α and γ
Jeong, H., Lee, J.-W., Kim, W., Choe, S. S., Kim, K.-H., Park, H. S., Shin, H., Lee, G., Shin, D., Lee, H., et al. (2011) · Diabetes · doi:10.2337/db09-1145 · Cited by 26
Globular adiponectin protects hepatocytes from tunicamycin-induced cell death via modulation of the inflammasome and heme oxygenase-1 induction
Khakurel, A., & Park, P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.010 · Cited by 30
Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice
Tsai, H.-P., Hou, P., Mao, F. C., Chang, C., Yang, W., Wu, C., Liao, H.-J., Lin, T.-C., Chou, L.-S., Hsiao, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010409 · Cited by 31

Authors: Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S.
Affiliations: University of Auckland (NZ)
University of Hong Kong (HK)
Corresponding author: Xu, Aimin
ORCID: Xu, Aimin
Wang, Yu
Lam, Karen S.L.
Cooper, Garth J.S.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2003-07-01
Volume: 112
Issue: 1
Pages: 91-100
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci200317797
PMC: PMC162288
OpenAlex: W2120590109
Cited by: 1,298
References: 68
Citations by year: 2026: 12 · 2025: 15 · 2024: 29 · 2023: 34 · 2022: 34 · 2021: 43 · 2020: 38 · 2019: 35 · 2018: 54 · 2017: 50 · 2016: 50 · 2015: 69 · 2014: 75 · 2013: 59 · 2012: 68
FWCI: 49.81
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: Auckland Medical Research Foundation
University of Hong Kong
Health Research Council of New Zealand
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords: adiponectin, alcoholic fatty liver, non-alcoholic fatty liver disease, hepatic steatosis, hepatomegaly, liver inflammation, TNF-α, carnitine palmitoyltransferase 1, hepatic fatty acid oxidation, fatty acid synthesis, acetyl-CoA carboxylase, fatty acid synthase, alanine aminotransferase, ob/ob mice, obesity
MeSH terms: Alanine Transaminase, Animals, Fatty Acids, Fatty Liver, Fatty Liver, Alcoholic, Liver, Male, Mice, Inbred C57BL, Obesity, Morbid, Oxidation-Reduction, Proteins, Recombinant Proteins, Tumor Necrosis Factor-alpha, Intercellular Signaling Peptides and Proteins, Mice, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks